Results 291 to 300 of about 99,805 (324)

Knowledge, attitudes, and practices of inpatients with chronic cardiovascular comorbidities regarding polypharmacy: a cross-sectional study. [PDF]

Front Pharmacol
Xu L, Zhuo C, Xu H, Xia Z, Wu M, Cai H.
europepmc   +1 more source

Trends in Drug-Related Mortality in Adults Aged 40-59 in the United States (2018-2023): A Proxy Analysis of Polypharmacy Using CDC WONDER (Wide-Ranging Online Data for Epidemiologic Research). [PDF]

Cureus
Laraib, Khalid U, Khalid A.
europepmc   +1 more source

Ginkgo biloba L. for Cognitive Impairment in the Context of Polypharmacy and Anticholinergic Burden – Real-World Evidence from Everyday Practice

Scholl, Annika Johanna, Drebka, Alexandra, Könnecke, Julie, Bößneck, Nele, Mösges, Ralph, Frenzel, Svenja Beatrice, Bachmeier, Beatrice Elisabeth   +6 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antipsychotic Polypharmacy

Current Pharmaceutical Design, 2004
The administration of more than one drug for a single medical condition is considered to be polypharmacy. There are many possible reasons for polypharmacy: (1) psychosis is a chronic disease that cannot be cured; (2) expectations to improve patients' quality of life beyond what drugs can actually do is high; (3) the lack of side effects and ...
J, Ananth, S, Parameswaran, S, Gunatilake   +2 more
openaire   +2 more sources

Polypharmacy in schizophrenia

Current Opinion in Psychiatry, 2010
Although most guidelines recommend monotherapy in schizophrenia, the combined application of multiple psychotropic agents is very common, especially in treatment-refractory cases. We review the empirical basis supporting these attempts and their relevance for clinical practice.Polypharmacy intends to address different aspects of treatment resistance ...
M, Zink, S, Englisch, A, Meyer-Lindenberg   +2 more
openaire   +3 more sources